Impact with Jackie Nespral
January 25, 2025
Jackie speaks to the co-chairs of the 2026 Miami Class Action Forum that is happening at the University of Miami
Click here to watch the original broadcast.
By Lisa Willis
Jan 21, 2025
The FTC’s new report on pharmacy benefit managers strengthens New Jersey’s insulin MDL, say Tal Lifshitz and Ben Wotlanzki. They argue the findings—revealing $7.3 billion in inflated drug revenues and broken rebate systems—reinforce arguments that PBMs manipulated insulin pricing. Their analysis predicts expanded litigation and heightened scrutiny of PBM practices in the MDL.
Click here to read the original article.
By Lisa Willis
Jan 17, 2025
Insulin MDL litigation is gaining momentum, bolstered by a fresh FTC report. Tal Lifshitz and Ben Wotlanzki emphasize that the agency’s findings reinforce allegations of anticompetitive behavior and pricing manipulation. They predict a surge in lawsuits targeting insulin manufacturers, setting the stage for intensified legal scrutiny and robust multidistrict litigation activity.
Click here to read the original article.
By Tommaso Baronio
January 15, 2025
A judge told attorneys to have a tête-à-tête. Plaintiff counsel paid the $74 bill, and the defense lawyer left a $74 tip.
Click here to read the original article.
By Brian Bandell
January 8, 2025
A local company bought the Miami Beach development site.
Click here to read the original article.
